RCK - Science based cannabis genetics
The chain begins with us.
The chain begins with us.
RCK - Science based cannabis genetics
RCK is a unique cannabis genetics R&D company, established in 2016 and headquartered in Israel. The company focuses on developing, breeding, and manufacturing elite cannabis strains and seeds. Their vision is to revolutionize the cannabis world by developing elite hybrid seeds through science-based genetics. With a mission to bring innovation to the biotechnology and food and beverage industries, RCK stands out in the cannabis market.
The company's last investment was a $700.00K seed round investment in January 2016. The investors for this round are not disclosed, but this injection of capital has likely contributed to the advancement of their cutting-edge genetics research and development.
With its expertise and focus on science-based genetics, RCK presents an intriguing opportunity for venture capitalists looking to enter the burgeoning cannabis market. The potential for disruption and innovation in this space makes RCK a compelling investment prospect, as they strive to redefine the possibilities within the cannabis industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $700.00K | - | 01 Jan 2016 |
No recent news or press coverage available for RCK - Science based cannabis genetics.
We care about your data, and we'd love to use cookies make your experience better.
